Absci

About Absci

Absci Corp is a synthetic biology company that integrates generative artificial intelligence (AI) with scalable wet lab technologies to accelerate biologic drug discovery and development. Its integrated drug creation platform leverages AI models and wet lab validation to design and optimize differentiated antibody therapeutics, including those targeting hard-to-drug targets. Absci's approach enables simultaneous optimization of multiple drug characteristics, aiming to improve the efficiency and success rate of biologic drug development. The company collaborates with partners across the pharmaceutical, technology, and academic sectors to advance novel biologics and therapeutic candidates.